Inaugural
Global Conference
Inaugural EF Hutton Global Conference
May 10th and May 11th, 2023
The Plaza Hotel, New York City
5th Avenue at Central Park South New York, NY 10019
We will be showcasing dynamic public and private companies across multiple sectors in an intimate conference setting, displaying a unique one-on-one format, as there will be no general presentations at the conference.
This two-day, invitation-only event features key executives from approximately 150 public and private companies to convey their unique stories to an extensive audience which includes institutional investors, high-net worth individuals, corporate clients, and exclusive members of the press. Investors and executives will have the opportunity to interact with each other in a friendly, high-energy environment.
B2I DIGITAL, Inc. is a marketing sponsor of the EF Hutton Global Conference. B2I DIGITAL, Inc. is not an affiliate of EF Hutton and is not authorized to represent or act on behalf of EF Hutton , in any capacity. EF Hutton has not reviewed and approved the content contained on the b2idigital.com website. Content about any specific company was provided and approved by that company. B2I DIGITAL, Inc. has not independently verified the accuracy of the information contained herein. No content contained herein shall be considered an offer to solicit the sale of any security.

AgriFORCE Growing Systems Ltd.
AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI; AGRIW) is an agtech company focused on building an integrated agtech platform that combines the best technology, intellectual property, and knowledge to solve an urgent problem – providing the best solutions to help drive sustainable crops and nutritious food for people around the world. The AgriFORCE vision is to be a global leader in delivering plant-based foods and products through an advanced and sustainable agtech platform that makes positive change in the world—from seed to table. Additional information about AgriFORCE is available at: www.agriforcegs.com.

CareCloud, Inc.
CareCloud offers technology solutions (a combination of software and services offering) for doctor’s offices and medical practices to drive revenue growth, workflow and operation efficiency, and transform patient experience. Its combination of software and service offerings include electronic health records, revenue cycle management, practice management, chronic care management, remote patient monitoring, business intelligence, telehealth, robotic process automation, mobile applications, workforce augmentation, and other services. Currently, ~40,000 providers leverage CareCloud solutions in 80 medical specialities.
Nasdaq: CCLD
IR Website: https://ir.carecloud.com/
Headquarters: Somerset, NJ

Agilyx
Agilyx, founded in 2004, is a leader in chemical plastics recycling solutions, positioned to solve and mitigate the global challenge of plastic waste. The company has developed a patented, flexible, commercially validated and scalable solution to convert waste plastic into recycled materials and products in a massive yet untapped market. With Cyclyx, a JV with ExxonMobil, Agilyx possesses the industry know-how of feedstock supply and management. Being a technology enabler that deploys an asset light model, Agilyx can scale many projects simultaneously and rapidly. ExxonMobil, Virgin, Mitsubishi Chemical and Technip Energies are several selected key partners of the company.
OTCQX: AGXXF
OSE: AGLX
IR Website: agilyx.com/investors
Headquarters: Portsmouth, New Hampshire

Agrify
Agrify is a leading provider of innovative cultivation and extraction solutions for the cannabis industry, bringing data, science, and technology to the forefront of the market. Our proprietary micro-environment-controlled Vertical Farming Units (VFUs) enable cultivators to produce the highest quality products with unmatched consistency, yield, and ROI at scale. Our comprehensive extraction product line, which includes hydrocarbon, ethanol, solventless, post-processing, and lab equipment, empowers producers to maximize the quantity and quality of extract required for premium concentrates. For more information, please visit Agrify at http://www.agrify.com.

Electrovaya Inc.
Electrovaya Inc. (TSX:EFL) (OTCQB:EFLVF) is a pioneering leader in the global energy transformation, focused on contributing to the prevention of climate change by supplying safe and long-lasting lithium-ion batteries without compromising energy and power.. Electrovaya is a technology-focused company with extensive IP, designs, develops, and manufactures proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications. To learn more about how Electrovaya is powering mobility and energy storage, please explore www.electrovaya.com.
Lantern Pharma is a clinical stage biotechnology company focused on innovating the cancer drug development process by using advanced genomics, machine learning, and artificial intelligence ("A.I."). Our A.I. platform, known as RADR®️, currently includes more than 25 billion data points, and uses big data analytics and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then to identify the cancer patients that we believe may benefit most from our compounds. RADR®️ is also used by Lantern and its collaborators to 1) develop and position new drugs and 2) to rescue and reposition drug candidates that others have tried, but failed, to develop.
Lantern’s current portfolio consists of four drug candidates and an ADC program across twelve disclosed tumor targets, including two Phase 2 programs and several additional Phase 1 clinical trials anticipated for 2023. Lantern seeks out experienced industry partners, world-class scientific advisors and innovative clinical-regulatory approaches to assist with its objective of delivering cancer therapies to patients as quickly and cost-effectively as possible. This data-driven, genomically-targeted and biomarker-driven approach allows us to pursue a transformational drug development strategy that identifies, rescues or develops, and advances potential small molecule drug candidates at what we believe is a fraction of the time and cost associated with traditional cancer drug development.

Cantargia is a clinical stage company developing novel therapies for both cancer and autoimmune/inflammatory disease. The lead program nadunolimab has generated positive interim results during treatment of pancreatic cancer, lung cancer and triple negative breast cancer. The development is now focusing on ongoing or upcoming randomized clinical trials in these diseases. The second program, CAN10, has shown potent activity in a number of models of autoimmune or inflammatory diseases and is entering phase I clinical development and the development is targeting myocarditis and systemic sclerosis. Cantargia is listed on NASDAQ Stockholm.

CEL-SCI Corporation (NYSE American: CVM) is a biotechnology company with the mission to improve the treatment of cancer and other diseases by utilizing the immune system. We completed a global pivotal Phase 3 study in head and neck cancer and reported data showing a significant survival benefit with no toxicity added in patients with advanced primary squamous cell carcinoma of the head and neck (SCCHN) who received its Multikine® immunotherapy prior to a standard of care (SOC) treatment of surgery plus radiotherapy as compared to patients who received SOC alone. Data from the Phase 3 study have been presented at the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) annual meetings in 2022. CEL-SCI is preparing to file a Biologic License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval and Multikine has received Orphan Drug designation from the FDA for this indication, SCCHN. The commercial scale buildout of its cGMP manufacturing facility is complete, and CEL-SCI is preparing it for inspection by the FDA in advance of Multikine’s commercial launch, pending FDA approval of the BLA.

Salem Media Group is America’s leading multimedia company specializing in Christian and conservative content, with media properties comprising radio, digital media and book and newsletter publishing. Each day Salem serves a loyal and dedicated audience of listeners and readers numbering in the millions nationally. With its unique programming focus, Salem provides compelling content, fresh commentary and relevant information from some of the most respected figures across the Christian and conservative media landscape. Learn more about Salem Media Group, Inc. at www.salemmedia.com, Facebook and Twitter.

Amprius Technologies
Amprius Technologies is at the forefront of transforming electric mobility with its revolutionary silicon anode lithium-ion battery. Its commercially proven batteries deliver unmatched performance – ultra-high energy density, high power density, extreme fast-charge rate capability, wide operating temperature, and long cycle life – required for aviation, aerospace, defense, and electric vehicles (EV). The company’s corporate headquarters is in Fremont, California, where it maintains an R&D lab and a pilot manufacturing facility.

Amprius Technologies
Reliance Global Group, Inc. (NASDAQ: RELI, RELIW) an InsurTech pioneer, is working to transform the traditional insurance agency model by combining artificial intelligence (AI) with the personalized experience of a traditional insurance agency model. Reliance Global Group’s growth strategy includes the organic expansion of its current portfolio of agencies owned in addition to the growth of 5MinuteInsure.com, its online business-to-consumer platform that utilizes artificial intelligence and data mining, to provide competitive insurance quotes within 5 minutes, and RELI Exchange, its B2B InsurTech platform and agency partner network for insurance agents and agencies, designed to give independent agents an entire suite of business development tools and the ability to effectively compete with national agencies. Additional information about the Company is available at relianceglobalgroup.com.

FiscalNote
FiscalNote is the leading technology provider of global policy and market intelligence. By uniquely combining AI technology, actionable data, and expert and peer insights, FiscalNote empowers customers with mission-critical insights and the tools to turn them into action.
We believe that leveraging technology is the key to providing transparency into the policy, people, and geopolitics shaping today’s world. Our technology sustains products and services that power clients around the world -- from small nonprofits to government agencies to large corporations (including more than half of the Fortune 100) -- with patented technology, expert analysis, and AI-powered data. Although our team and products have evolved significantly over time, we’ve never wavered from our north star to deliver novel, innovative, and compelling solutions to meet today’s most pressing challenges.
Home to CQ, FrontierView, Oxford Analytica, VoterVoice, and many other industry-leading brands, FiscalNote helps organizations stay ahead of rapidly evolving political, corporate, and regulatory environments.

Graphex Group Limited
Graphex Group Limited is a Cayman Island company with principal and administrative offices in Hong Kong and subsidiary office in Royal Oak, MI. Graphex is a global leader in the industry focused on the development of technologies and products for the enhancement of renewable energy, particularly the enrichment of spherical graphite and graphene, key components for Electric Vehicle (EV) batteries, Lithium-ion batteries, and other use cases. Proficient in commercial deep processing of graphite, Graphex has been consistently producing over 10,000 metric tons of spherical graphite annually for over 9 years. With a strategy to expand its global operations to support energy transition and electrification efforts worldwide, Graphex Group is currently among the top suppliers of specialized spherical graphite to the EV and renewable energy industries and holds patents in areas including products, production methods, machinery design, and environmental protection.

Orgenesis Inc.
Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies. www.orgenesis.com.
Innoviva
Innoviva is a diversified biopharmaceutical company with a portfolio of royalties and a growing portfolio of innovative healthcare assets
-
Royalty portfolio consists of respiratory products that were jointly developed with, and are licensed to, GSK and collectively make up a large portion of GSK’s leading respiratory franchise (RELVAR®/ BREO® ELLIPTA®, ANORO® ELLIPTA®)
-
Integrated hospital / infectious disease business formed via recent acquisitions of Entasis Therapeutics and La Jolla Pharmaceutical companies with strong growth prospects and significant operating leverage
-
Strategic healthcare assets in areas with high unmet medical need and significant long-term value creation potential, including a majority stake in bacteriophage leader Armata Pharmaceuticals
Pasithea Therapeutics
Pasithea Therapeutics is a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders.

Stran & Company, Inc.
Over the past 27 years, Stran has grown to become a leader in the promotional products industry, specializing in complex marketing programs to help recognize the value of promotional products, branded merchandise, and loyalty incentive programs as a tool to drive awareness, build brands and impact sales. Stran is the chosen promotional programs manager of many Fortune 500 companies, across a variety of industries, to execute their promotional marketing, loyalty and incentive, sponsorship activation, recruitment, retention, and wellness campaigns. Stran provides world-class customer service and utilizes cutting-edge technology, including efficient ordering and logistics technology to provide order processing, warehousing and fulfillment functions. The Company’s mission is to develop long-term relationships with its clients, enabling them to connect with both their customers and employees in order to build lasting brand loyalty. Additional information about the Company is available at: www.stran.com.

Spok, Inc.
Spok, Inc. is proud to be a global leader in delivering clinical communications to healthcare providers. Organizations rely on Spok for its contact center optimization solutions, web directory, secure texting, workflow improvement, and paging services, among other services. Spok has the largest installed base of pagers in the U.S. – over 800,000 – and provides centralized communication solutions to over 2,200 hospitals. Top hospitals rely on the Spok Care Connect® platform to enhance workflows for clinicians and support administrative compliance.
Spok, Inc., is a wholly owned subsidiary of Spok Holdings, Inc.
NASDAQ: SPOK
Headquarters: Alexandria, Virginia
www.spok.com
AgriFORCE Growing Systems Ltd.
AgriFORCE Growing Systems Ltd.
Nasdaq: AGRI